Lispro NL-ELISA

Lispro NL-ELISA

Lispro NL-ELISA

(10-1291-01)

Kit format: 1 x 96 wells

Measurement range: 1 - 500 mU/L

Optimized for pharma use

No cross-reactivity to endogenous insulin or other insulin analogs e.g. glargine

No interference from insulin auto-antibodies

Fully validated for use with human and pig samples, partially validated for rat samples

Controls included in the kit

TALK TO A PERSON
Description

Mercodia Lispro NL-ELISA is designed to be an excellent assay for pharma use.

The Mercodia Lispro NL-ELISA provides a chemiluminescent method for the quantitative determination of insulin lispro. The kit includes six calibrators, two anchor points and controls in serum matrix. Validation data available.

Test characteristics
Species

Human and Porcine

Samples

Serum, EDTA plasma and P-800 plasma

Sample volume

10 µL

Assay range

1 - 500 mU/L

Detection limit

≤0.36 mU/L

Incubation

1h + 1h + 10 min

Detection method

Chemiluminescence

specificity

The following cross-reactions have been tested:

Human insulin

Not detected

Human proinsulin

Not detected

Glargine

Not detected

Glargine M1

Not detected

Glargine M2

Not detected

Degludec

Not detected

Determir

Not detected

Insulin NPH

Not detected

Aspart

Not detected

Glulisine

Not detected

Porcine insulin

Not detected

Porcine proinsulin

Not detected

directions for use Certificate of Analysis Safety Data Sheet
directions for use
LOT. NO. DOCUMENT
32438 DfU - 10-1291-01 v. 3.0
Certificate of Analysis
LOT. NO. DOCUMENT
32438 CoA - 10-1291-01
31214
Safety Data Sheet
DOCUMENT
SDS - 10-1291-01

For other languages and previous versions: Technical Library

Question about the product? Contact us

Andreas Almlén

Key Account Manager Distributors and OEM

(+46) 70 780 95 09 BOOK A MEETING
Lispro NL-ELISA

Lispro NL-ELISA

(10-1291-01)

ASK A QUESTION OR BOOK A MEETING?
WE WILL HELP YOU

Andreas Almlén

Key Account Manager Distributors and OEM

(+46) 70 780 95 09 BOOK A MEETING